BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30571494)

  • 1. Use of Spontaneous Reporting Systems to Detect Host-Medication Interactions: Sex Differences in Oral Anti-Diabetic Drug-Associated Myocardial Infarction.
    Wang SH; Chen WJ; Hsu LY; Chien KL; Wu CS
    J Am Heart Assoc; 2018 Nov; 7(22):e008959. PubMed ID: 30571494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke.
    Floyd JS; Wiggins KL; Christiansen M; Dublin S; Longstreth WT; Smith NL; McKnight B; Heckbert SR; Weiss NS; Psaty BM
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):151-60. PubMed ID: 26547662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.
    Asche CV; McAdam-Marx C; Shane-McWhorter L; Sheng X; Plauschinat CA
    Drugs Aging; 2008; 25(7):611-22. PubMed ID: 18582148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
    Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
    Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.
    Tzoulaki I; Molokhia M; Curcin V; Little MP; Millett CJ; Ng A; Hughes RI; Khunti K; Wilkins MR; Majeed A; Elliott P
    BMJ; 2009 Dec; 339():b4731. PubMed ID: 19959591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.
    Filion KB; Douros A; Azoulay L; Yin H; Yu OH; Suissa S
    Br J Clin Pharmacol; 2019 Oct; 85(10):2378-2389. PubMed ID: 31276600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
    Umetsu R; Nishibata Y; Abe J; Suzuki Y; Hara H; Nagasawa H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2014; 134(2):299-304. PubMed ID: 24492232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of incident oral antidiabetic drugs on kidney function.
    Hung AM; Roumie CL; Greevy RA; Liu X; Grijalva CG; Murff HJ; Ikizler TA; Griffin MR
    Kidney Int; 2012 Apr; 81(7):698-706. PubMed ID: 22258320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
    Motola D; Piccinni C; Biagi C; Raschi E; Marra A; Marchesini G; Poluzzi E
    Drug Saf; 2012 Apr; 35(4):315-23. PubMed ID: 22376166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.
    Vaughan EM; Rueda JJ; Samson SL; Hyman DJ
    Curr Diabetes Rev; 2020; 16(8):851-858. PubMed ID: 32026779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
    Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
    Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study.
    Gorricho J; Garjón J; Alonso A; Celaya MC; Saiz LC; Erviti J; López A
    Br J Clin Pharmacol; 2017 Sep; 83(9):2034-2044. PubMed ID: 28294379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse Association between Metformin and Amiodarone-Associated Extracardiac Adverse Events.
    Kinoshita S; Hosomi K; Yokoyama S; Takada M
    Int J Med Sci; 2020; 17(3):302-309. PubMed ID: 32132864
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
    Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
    Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke.
    Floyd JS; Wiggins KL; Sitlani CM; Flory JH; Dublin S; Smith NL; Heckbert SR; Psaty BM
    Diabetes Obes Metab; 2015 Dec; 17(12):1194-7. PubMed ID: 26179389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study.
    Morgan CL; Mukherjee J; Jenkins-Jones S; Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):957-62. PubMed ID: 24720708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.